Table 4 Correlation between OS and clinical-pathological data in a univariate analysis
5 years-OS (%) | 95%CI | p | |
|---|---|---|---|
Age | 0.2 | ||
< 50 | 86 | 0.79–0.91 | |
≥ 50 | 82 | 0.76–0.88 | |
VD level | 0.3 | ||
< 20 ng/mL | 82% | 0.75–0.88 | |
≥ 20 ng/mL | 85% | 0.79–0.9 | |
Clinical stage | 0.00001 | ||
I-II | 89% | 0.84–0.93 | |
III | 72% | 0.61–0.80 | |
pCR | 0.0007 | ||
no | 79% | 0.73–0.84 | |
yes | 94% | 0.86–0.98 | |
Tumor subtypes | 0.00001 | ||
HER2+ | 90% | 0.82–0.95 | |
HR+/Her2- | 92% | 0.86–0.96 | |
TNBC | 65% | 0.53–0.74 | |
SBR grade | 0.4 | ||
II | 86% | 0.79–0.91 | |
III | 83% | 0.76–0.88 |